Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
03/2009
03/18/2009CN101386596A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
03/17/2009US7504519 e.g. N-Methoxycarbonyl-4-(4,5-dihydro-5-phenyl-3-trifluoromethyl-pyrazole-1-yl)-benzenesulphonamide; antiinflammatory and analgesic agent
03/17/2009US7504518 reacting a pyrazole compound with an ethylenically unsaturated group-containing isocyanate compound; no need to use any inert solvent such as toluene or xylene, safety to the human body and environment is excellent and the production processes and equipment can be simplified
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504424 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009US7504362 Pesticidal compositions
03/17/2009US7503965 Azo compound, ink composition, and colored object
03/12/2009WO2009032249A1 Soluble guanylate cyclase activators
03/12/2009US20090069572 Process for the preparation of pyrazoles
03/12/2009US20090069571 Reacting 5-amino-1-phenylpyrazole with alkylthioalkyl chloride in presence of basic potassium salt and nitrile
03/12/2009US20090069398 Pyrazolyl Carboxamides
03/12/2009US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069288 Novel therapeutic compounds
03/12/2009US20090069184 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles and their use as herbicides
03/12/2009CA2698742A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/11/2009EP2033955A1 Urea derivatives of 1H-pyrazol-4-carboxylic acid with neutrophil chemotaxis inhibiting activity
03/11/2009EP2032535A1 Spirocyclic nitriles as protease inhibitors
03/11/2009EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
03/11/2009CN101384556A Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/11/2009CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/10/2009US7501527 Method for the production of fluoromethyl-substituted heterocycles
03/10/2009US7501449 2H -or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
03/10/2009US7501446 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors
03/10/2009US7501444 3-Pyrid-3-yl- pyrazoles in which pyrazole ring is additionally substituted with a halogenated phenyl group; prenyl-protein transferase inhibitors
03/05/2009WO2009029499A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/05/2009WO2009028727A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same
03/05/2009WO2009028655A1 Heterocyclic compound and use thereof
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide
03/05/2009WO2009026658A1 Ppar agonists
03/05/2009WO2009010416A3 Inhibitors of 11b-hydroxysteroid dehydrogenase
03/05/2009WO2008145681A3 Ccr2 receptor antagonists and uses thereof
03/05/2009WO2008140338A4 New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses
03/05/2009WO2008129157A4 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
03/05/2009WO2008110846A3 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
03/05/2009US20090062552 Process for the preparation of a carboxamide derivative
03/05/2009US20090062540 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062365 Pyrazoles for the Treatment of GERD and IBS
03/05/2009US20090062364 Deuterium-enriched celecoxib
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009US20090056586 Yellow dye compound and ink composition comprising the same
03/05/2009CA2697663A1 Substituted pyrazole derivative
03/05/2009CA2697368A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/04/2009EP2029550A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
03/04/2009EP2029549A2 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
03/04/2009EP2029548A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
03/04/2009EP2029547A1 Fxr agonists
03/04/2009EP2029546A1 Aryl-substituted heterocycles, and use thereof
03/04/2009EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides
03/04/2009CN101379039A Carboxamides for controlling micro-organisms in plant and material protection
03/04/2009CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009CA2393197C Control of arthropods in animals with 1-arylpyrazoles
02/2009
02/26/2009WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis
02/26/2009WO2009024342A2 Novel microbiocides
02/26/2009US20090054662 Process for synthesizing a substituted pyrazole
02/26/2009US20090054661 Method for Producing Carboxamides
02/26/2009US20090054660 Method for producing carboxamides
02/26/2009US20090054496 N-[o-(cyclopropylcyclobutyl)phenyl]heterocyclecarboxamides, for use in agriculture or horticulture for controlling or preventing infestations of plants by phytopathogenic microorganisms, especially fungi.
02/26/2009US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors
02/26/2009US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents
02/26/2009US20090054431 Novel heterocycle compounds
02/26/2009US20090054430 Inhibitors of Protein Kinases
02/26/2009US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment
02/26/2009US20090054401 Substituted bicyclic derivatives and use thereof
02/26/2009US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound
02/26/2009US20090054240 Heteroaroyl-substituted Alanines
02/26/2009DE102007040243A1 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-dehydrogenase type 1 Hydroxysteriod inhibitors for the treatment of hormone-dependent diseases
02/25/2009EP2027119A2 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
02/25/2009EP2027113A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
02/25/2009EP2027095A1 Heteroaroyl-substituted alanines with a herbicidal action
02/25/2009EP2026799A2 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
02/25/2009CN101374816A Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
02/25/2009CN101374810A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/25/2009CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
02/25/2009CN101372476A Method for synthesizing pyrazole heterocycle without catalyst or solvent
02/24/2009US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone
02/24/2009US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease
02/24/2009US7495015 Inhibitors of p38 Mitogen-activated protein kinases (MAP kinases); arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, chronic obstructive pulmonary disease, Alzheimer's disease; 6-(2-Fluoro-phenoxy)-3-phenyl-1H-indazole for example
02/24/2009CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
02/24/2009CA2297406C Tricyclic vasopressin agonists
02/19/2009WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
02/19/2009WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists
02/19/2009WO2009021747A2 Treatment of duchenne muscular dystrophy
02/19/2009WO2008130630A3 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof
02/19/2009WO2008038143A3 Novel solid forms of rimonabant and synthetic processes for their preparation
02/19/2009US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders
02/19/2009US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
02/19/2009US20090048226 Inhibitors of caspases
02/19/2009US20090048112 Novel Herbicides
02/19/2009US20090044348 3-amino-2-{[(1E)-2-amino-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene]amino}-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one; 3-amino-4-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl) imino]cyclohexa-2,5-dien-1-ylidene}-N-methylmethanaminium perchlorate for coloring keratin fibers; leuco dye
02/19/2009CA2696006A1 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
02/19/2009CA2694993A1 1,2-diamido-ethylene derivatives
02/19/2009CA2685582A1 Treatment of duchenne muscular dystrophy
02/18/2009EP2025676A1 Novel indazole derivative having spiro ring structure in side chain
02/18/2009EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 256